URSA-QUALITY-ADD1: ADD-E Initiation Phase (ADD1)

Measure Description

The percentage of members 6–12 years of age with a prescription dispensed for ADHD medication, who had one follow-up visit with a practitioner with prescribing authority during the 30-day initiation phase. Unadjusted Certified Measure 8d315e71-a472-4e0c-b8ef-4e117932d51b

Metadata

• Measure Type: Rate Measure
• Temporal Structure: Entity
• Component Class: Long-Form
• Denominator Case Field: Index Patient ID, Output NCQA Payer Type Code
• Target Direction: None

Denominator Description

Patients aged 6-12 years old who were dispensed an ADHD medication during the 12-month intake period.

Numerator Description

Qualifying denominator patients who had a follow-up visit with a practitioner with prescribing authority within 30 days following the index prescription start date.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).